Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PbrFEN-1 positively regulates pear pollen tube growth and is involved in the self-incompatibility response.

Plant reproduction·2026
Same author

Transition Metal-Stabilized Lanthanide Sulfide Nanocrystal Libraries: A New Platform for Solar-to-Hydrogen Conversion.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Study on the therapeutic effects of the primary active ingredients in cinnamon oil for constipation-predominant irritable bowel syndrome and their regulatory effects on the 5-HT signaling pathway and gut microbiota.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Daptomycin-resistant Staphylococcus capitis: mechanisms, molecular epidemiology, and clinical aspects.

Journal of global antimicrobial resistance·2026
Same author

An efficient woody plant protoplast platform enables transgene-free multiplex genome editing and rapid trait validation in pear.

Journal of experimental botany·2026
Same author

Explore the Heterogeneity of Glioblastoma Based on Genes Related to Glutamine Metabolism.

Cancer informatics·2026

Related Experiment Video

Updated: Jun 7, 2026

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis.

Cheng Tang1, Su-Xia Sun1, Chao Gu2

  • 1Department of Respiratory Medicine, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

BMC Cancer
|January 28, 2025
PubMed
Summary
This summary is machine-generated.

High levels of tRNA-derived small RNAs (tsRNAs) show potential as biomarkers for diagnosing lung cancer (LC) and predicting patient prognosis. Further research is needed to confirm these findings.

Keywords:
DiagnosticLung cancerMeta-analysisPrognostictsRNAs

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 7, 2026

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Biomarkers
  • Molecular Oncology
  • Diagnostic Accuracy

Background:

  • Lung cancer (LC) is a leading cause of cancer mortality worldwide.
  • tRNA-derived small RNAs (tsRNAs) are emerging as critical players in LC development.
  • Investigating tsRNAs as novel biomarkers for LC is essential.

Purpose of the Study:

  • To evaluate the diagnostic and prognostic value of differentially expressed tsRNAs in lung cancer.
  • To conduct a meta-analysis of existing studies on tsRNAs in LC.

Main Methods:

  • Systematic literature search of PubMed and Web of Science up to January 10, 2024.
  • Meta-analysis using diagnostic odds ratios (DORs) and area under the receiver operating characteristic curve (AUCs) for diagnosis.
  • Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were used for prognostic analysis.

Main Results:

  • Twelve studies were included, indicating tsRNAs have diagnostic potential for LC (combined DOR=7.32, AUC=0.81).
  • Serum tsRNA levels demonstrated strong diagnostic efficacy (DOR=16.56, AUC=0.88).
  • Elevated tsRNA levels were significantly associated with poorer LC patient prognosis (HR=1.59, 95% CI: 1.33-1.90).

Conclusions:

  • High tsRNA levels show promise for both diagnosing lung cancer and predicting patient outcomes.
  • Further high-quality studies are warranted to validate these findings and clinical utility.